Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2574707013 | Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2578104016 | Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580414010 | Amphotericin (colloidal dispersion) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580415011 | Amphotericin (lipid complex) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2580416012 | Amphotericin (liposomal) 5mg/mL suspension for injection 20mL vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | est un(e) (attribut) | Product containing amphotericin B liposome (medicinal product) | false | Inferred relationship | Some | ||
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | a pour principe actif (attribut) | Amphotericin B liposome (substance) | false | Inferred relationship | Some | ||
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | est un(e) (attribut) | Amphotericin-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | a une forme pharmaceutique (attribut) | suspension injectable | false | Inferred relationship | Some | ||
| Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial (product) | est un(e) (attribut) | Product containing amphotericin B liposome in parenteral dosage form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR